The tendency has been increasing ever since the last year, after the pandemic was officially affirmed, with people having to rely on online assets to get their meds at a time when the need for quality healthcare became paramount.
Recently, India’s healthcare transportation continues to endure, smart solutions are needed. With this in mind, online pharmacy ‘PharmEasy’ has procured its challenger Medlife, welcoming it to its folks of healthcare services.
PharmEasy, states, “We are thrilled to welcome Medlife to the PharmEasy family! We can’t wait to innovate together and deliver better experiences for our consumers, delivery personnel, and retail partners across the country.”
With this unification, Medlife’s customers will involuntarily become PharmEasy customers, with the former discontinuing its operation starting 25th May. Medlife customers can log in to the PharmEasy app to start using their Medlife account without having to sign up from the same number once again. Likewise, all their digitized prescriptions and saved addresses dating back to a year will involuntarily be accessible on the PharmEasy app. Medlife and PhamEasy operate in the same market, and thus, this attainment will help the latter gain a huge influx of new customers directly.
The online Medicare market has been mounting exponentially more the last year-a phenomenon which has reaped enormous dividends for PharmEasy. Its parent company API Holdings recently broke into the unicorn club with a massive valuation of 1.5 Billion. Moreover, demand has been rising even more over the last few months, after the second wave of COVID 19 led to shutdowns in almost every part of India once again. Thus, PharmEasy is looking to better its offering, and this acquisition is a step towards achieving that goal.
The Company, states, “This acquisition significantly strengthens our position in the healthcare industry, and further helps us in providing quality healthcare to more number of Indian households. Moving forward, we aim to be of even better service to the people.”